4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-056152
President and CEO sold 3,493 shares at $4.54 ($15,858)
From the SEC's structured data for this filing
Trades in this filing
Paulson Richard A. · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-11-04 | Sale : show line 1 in the form | −3,493 | $4.54 | $15,858 | 616,017 | D |
| Open-market sales · 3,493 sh · avg $4.54 · $15,858 | ||||||
Loading xslF345X03/doc4.xml…